Stay updated on Formoterol-beclomethasone in Bronchiectasis: Clinical Trial
Sign up to get notified when there's something new on the Formoterol-beclomethasone in Bronchiectasis: Clinical Trial page.

Latest updates to the Formoterol-beclomethasone in Bronchiectasis: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the bronchiectasis trial is displayed, with its study design, treatment arms, eligibility criteria, locations, and outcome measures. The record also indicates the study was terminated because of an insufficient inclusion rate during the COVID-19 pandemic.SummaryDifference51%

- Check15 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2 while the study page continues to show a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error page with a simple header and navigation, indicating access to the study record is blocked. The addition reflects an access restriction state rather than updating core study data.SummaryDifference18%

Stay in the know with updates to Formoterol-beclomethasone in Bronchiectasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Formoterol-beclomethasone in Bronchiectasis: Clinical Trial page.